Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) regularly issues news and updates that shed light on its role as the world’s largest diversified manufacturer of professional dental products and technologies. Company press releases cover topics such as strategic partnerships, leadership changes, financial results and portfolio decisions, giving investors and dental professionals insight into how the business is evolving.
Recent news has highlighted Dentsply Sirona’s focus on connected dentistry and technology-enabled solutions. The company has announced expanded and renewed distribution partnerships in the United States that provide access to its dental technology portfolio, including systems and imaging solutions referenced in those agreements. These announcements emphasize integrated ecosystems that connect devices, software and services from scanning through design and manufacturing workflows.
News items also address corporate strategy and performance, including quarterly financial results and the introduction of a Return-to-Growth action plan. In these updates, Dentsply Sirona outlines priorities such as putting customers at the center, strengthening the U.S. business, and evolving operations to support innovation and training. Leadership appointments in commercial, finance and regional roles are frequently reported, reflecting the company’s efforts to align its organization with these priorities.
Other press releases describe decisions about the Wellspect Healthcare business, dividend declarations, participation in investor conferences and the conclusion of an SEC Division of Enforcement investigation without enforcement action. Together, these news items provide a detailed view of how Dentsply Sirona manages its portfolio, governance and capital allocation. Readers interested in XRAY can use this news feed to follow developments in connected dentistry, strategic partnerships, governance actions and financial communications from the company.
DENTSPLY SIRONA (XRAY) reported second-quarter 2021 revenues of $1,067 million, a substantial 117.3% increase from $491 million in Q2 2020. GAAP EPS stood at $0.45 compared to a loss of ($0.44) in 2020, while Non-GAAP EPS rose to $0.71 from a loss of ($0.18). Operating income also improved significantly, reaching $155 million from a loss of ($104 million). The company reaffirmed its FY21 Non-GAAP EPS outlook at $2.75 to $2.90 amidst a recovering dental market.
Dentsply Sirona announced an investor conference call on August 5, 2021, at 8:30 am ET to review its financial results. The call will be accessible via a live webcast on the Company’s investor website. Participants can dial +1-877-370-7637 for domestic calls or +1-629-228-0723 internationally, using conference ID # 4184820. A replay will be available for one week post-call. Dentsply Sirona is the world's largest manufacturer of dental products, and its stock is traded on Nasdaq under the symbol XRAY.
Dentsply Sirona (Nasdaq: XRAY) has acquired Propel Orthodontics for $131 million in cash. The acquisition includes Propel's VPro device and the Fastrack Mobile App, enhancing Dentsply's position in the growing clear aligner market. Propel Orthodontics is recognized for its innovative orthodontic devices and offers solutions for both in-office and at-home use. This strategic move aims to complement Dentsply's existing Byte® and SureSmile® businesses, reinforcing its commitment to advancing patient care in dentistry.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) has announced a 10% increase in its quarterly dividend, raising it from $0.10 to $0.11 per share. The new dividend will be paid on July 9, 2021 to shareholders on record by June 25, 2021. This decision reflects the company’s ongoing commitment to provide value to its investors while maintaining its standing as a leading manufacturer of dental products.
Dentsply Sirona (Nasdaq: XRAY) will participate in four investor conferences in June 2021. Key events include:
- William Blair 41st Annual Growth Stock Conference on June 2 at 9:40am ET
- Stifel 2021 Virtual Jaws & Paws Conference on June 3 at 10:00am ET
- Goldman Sachs 42nd Annual Global Healthcare Conference on June 9 at 9:40am ET
- Baird 2021 Healthcare ESG Symposium on June 17 at 10:40am ET
Live webcasts can be accessed through the Dentsply Sirona website, with replays available afterward.
Dentsply Sirona (Nasdaq: XRAY) reported strong first quarter 2021 results with revenue of $1,027 million, a 17.5% increase from $874 million in Q1 2020. GAAP EPS rose to $0.53 compared to a loss of ($0.63) last year. Non-GAAP EPS increased 67.4% to $0.72. Operating income also improved, reaching $154 million versus a loss of ($125 million) in 2020. The company raised its FY21 Non-GAAP EPS outlook to $2.75 to $2.90, reflecting optimism about the dental market recovery.
Dentsply Sirona, the world's largest manufacturer of dental products, will host an investor conference call and webcast on May 6, 2021, at 8:30 am ET. An earnings press release will be issued that morning. Investors can access the event via the link on Dentsply Sirona’s website. For participation, domestic callers can dial +1-877-370-7637, while international callers can reach +1-629-228-0723, using Conference ID # 3396419. A replay will be available for one week post-call. Dentsply Sirona focuses on innovative dental solutions, and its shares are listed on Nasdaq under the symbol XRAY.
Dentsply Sirona (Nasdaq: XRAY) will participate in the 2021 Barclays Global Healthcare Conference on March 10, 2021. CEO Don Casey is set to join a fireside chat at 1:15 PM ET, which can be accessed via a live audio webcast on the company’s website. A replay will also be available post-event. As the world’s largest manufacturer of professional dental products, Dentsply Sirona has a rich history of 134 years in the dental industry, providing innovative solutions to enhance patient care.
North American Dental Group (NADG) and Dentsply Sirona have announced an expanded partnership aimed at enhancing patient care through advanced digital solutions. This new agreement gives NADG-supported dentists improved access to scanning and imaging technologies, such as Primescan, to support treatments like SureSmile clear aligners and guided implant surgery. The collaboration includes a robust education and training program to establish evidence-based clinical standards across NADG's 250 dental offices in 15 states, emphasizing the commitment to delivering exceptional oral care.
DENTSPLY SIRONA reported Q4 2020 revenue of $1.08 billion, down 2.6% from $1.1 billion in Q4 2019. GAAP EPS fell by 2.2% to $0.45, while non-GAAP EPS rose 19.2% to $0.87. For FY20, total revenue dropped 17.1% to $3.34 billion. Operating cash flow for FY20 remained strong at $635 million. The company announced a fiscal year 2021 outlook, projecting revenue between $4.0 billion and $4.3 billion, representing a growth of 20% to 30%. Non-GAAP EPS for FY21 is expected to range from $2.60 to $2.80.
FAQ
What is the current stock price of Dentsply Sirona (XRAY)?
What is the market cap of Dentsply Sirona (XRAY)?
